reason report
showcas strength biz model posit read-across
bottom line rais pt post strong
report showcas strength busi
model re-instil confid offer favor read-
across group expect continu earn upsid
rais ep back
solid quarter thirteen percent top-lin adj ep growth yoy
continu showcas strength busi model
synergist across optum uhc optum optum insight
grow solid doubl digit optum rx yoy rx script
growth expand overal optum margin bp yoy
within uhc medicar remain strongest growth segment though
commerci growth expect pick multipl
price-to-earnings forward ep expand recent news-flow
enter hospit drug suppli chain entrench
competit logist challeng similarli drug suppli chain
price reform pois manifest tame rfi hh
schedul speech rx drug price presid trump
april also like drive generalist money sidelin
solid rais ep beat
rais beat driven larg came better bp
despit flu offer favor read-across group conserv
estim dcp roughli flat qoq yoy cfo
ni exhibit
impress revenu growth uhc enjoy share gain
medicar particular steadi margin commerci growth
pois pick optum optum insight grow
solid doubl digit optum rx saw rx script growth
membership mm member exhibit
focu compani well look solidli
revenu growth maintain expand margin
manag commentari call point observ price
pressur commerci date focu price action
drive membership gain steadi expand margin well
focu appear leverag solid rate increas privat
third senior toward half us senior popul exhibit
base price-to-earnings
ep
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
revenu billion ep dilut show ep exclud non-cash amort year quarterli
number may sum full-year number due round
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
rais ep
beyond take account season pressur
banmedica well normal season high deduct
plan factor part tailwind medic cost
tax rate uptick contempl reduc stock compens
synergi optum uhc offer uniqu differenti
competit advantag optum rx optum drive cost
structur advantag drive share gain uhc uhc offer
first-mov advantag optum contract aco value-
base care multi-payor model abco deal offer strateg
relationship contract health system across uhc optum
larri renfro remain activ involv optum transit
evp strateg relationship andrew witti take role optum
capit deploy unchang i-day despit front-
load share buy-back given market condit deal activ like
pick accord previous articul prioriti optum
build-out target market exhibit
multipl continu expand confid
fundament restor overhang entri
reform drug suppli chain ebb rais pt
contempl price-to-earnings ep
speech presid april well beat
disclosur like catalyst exhibit
rais pt post strong report showcas
strength busi model re-instil confid offer favor read-
across group
expect continu earn upsid rais ep
back solid quarter thirteen percent top-lin adj ep growth yoy continu
showcas strength busi model synergist across optum uhc
optum optum insight grow solid doubl digit optum rx yoy rx
script growth expand overal optum margin bp yoy within uhc
medicar remain strongest growth segment though commerci growth expect pick
multipl price-to-earnings forward ep expand recent
news-flow enter hospit drug suppli chain entrench competit
logist challeng similarli drug suppli chain price reform pois manifest
tame rfi hh schedul speech presid trump april also
like drive generalist money sidelin
ep beat rais beat driven larg came
better bp despit flu offer favor read-across group conserv
estim dcp roughli flat qoq yoy cfo ni
quarter solid ep
total optum revenu includ elimin mm
unitedheatlhgroup earningsreport estimatesconsensu estimatesreport sequentialreport rx inc
estim bp off-set sg miss despit flu
unitedheatlhgroup metricsreport estimatesconsensu estimatesreport sequenti bp report yoy bp metricsconsolid oper oper oper tax cost day cfo/net quarter impact influenza mcr would basi point thing like point though think way think flu one factor often occur given year expect us alway best manag provid good care access patient control cost appropri john offic ceo evp cfo inc con call inc
day claim payabl larg steadi day
uhc enjoy share gain medicar particular steadi margin commerci
growth pois pick optum optum insight grow solid doubl
digit optum rx saw rx script growth expand margin consider
banmedica deal close bring membership mm member
unitedheatlhgroup membership estim consensu estim report sequentialreport servedcommerci medicar public medic part leerink consensu estim commerci risk-bas includ total commerci includ tricar unitedhealth group inc
margin across optum busi expand yoy
focu compani well look solidli revenu growth
maintain expand margin
manag commentari call point observ price pressur commerci
date focu price action drive membership gain steadi expand
well focu appear leverag solid rate increas privat
third senior toward half us senior popul
report estimatesconsensu estim beat/miss leerink report estimatesconsensu estim estimatesreport marginsearn mm revenu mm unitedhealth group inc
commerci busi focu maintain fine balanc growth margin
unitedhealthcar employ individu commerci group full-risk grew peopl past year despit person decreas quarter consist outlook last call expect grow categori balanc year steven nelson evp ceo-uhc inc con callto quarter specif continu well small busi particularli import market segment us middl market result temper share investor confer last quarter realli relat competitor chose address reintroduct health insur tax employ custom level maintain focu price cost includ frankli think struck right balanc given middl market sell season concentr first half year see us return growth progress year tell consist guidanc provid investor confer daniel schumach presid unit healthcar servic inc con group fi membership group si membership inc
expect continu market share gain solid rate increas
note total industri membership april report year
alway tri keep benefit premium network pharmaci stabl possibl particip way enhanc retent also ensur consist qualiti highhealthcar david scott wichmann ceo director inc con calla said look forward encourag direct rate nearli point versu last year think import rememb context backdrop program chronic underfund past nine year rate need necessari cover program cost keep benefit stabl strong senior help continu advanc qualiti innov look forward signal expect long-term growth rate medicar advantag around think ebb flow mildli would look still expect probabl within rang know cours past four year meaning outperform gain share brian thompson ceo-uhc medicar retir inc con share membership membership market share unhtot industrymarket share inc
manag commentari support view increas privat
expect penetr increas current senior senior
rais ep beyond
take account season pressur banmedica well normal
season high deduct plan factor part tailwind medic cost
tax rate uptick contempl reduc stock compens
optim usher senior valu medicar advantag offer realli industry-wid said medicar advantag market continu sever under-penetrated today see path mention previous next year believ set polici fund see enabl regard expect realli good broad-bas benefit stabil optimist industri posit think great senior program popular larg brian thompson ceo-uhc medicar retir inc con penetr inc
ep estim top end guidanc rang
net bpscash consensusrevenu amort earn weighted-avg share net net ep flow oper paid repurchas expenditur guidanc investor updat guidanc updat guidanc unitedhealth group inc
synergi optum uhc offer uniqu differenti competit advantag
optum rx optum drive cost structur advantag drive share gain
uhc offer first-mov advantag optum contract aco value-bas care
multi-payor model abco deal offer strateg relationship contract health
system across uhc optum larri renfro remain activ involv optum
transit evp strateg relationship andrew witti take role optum ceo
abco relationship leverag contract strateg health system
pleas progress make align expect rel integr advisori board organ optuminsight fulli integr provid go-to-market team consult servic busi result see favor market recept pipelin develop across provid busi also launch within research busi expans payer market second quarter year life scienc market pleas progress make put advisori board organ togeth optuminsight eric murphi ceo optuminsight inc inc con call inc
continu growth optum insight
capit deploy unchang i-day despit front-load share buy-back given
market condit deal activ like pick accord previous articul
prioriti optum build-out target market
debt cap current
share buy-back plan unchang i-day
cap ratioso still commit long-term debt-tocap ratio chang view expect zone zone term share repurchas activ quarter billion still track full-year outlook billion billion said still highli commit debt-to-tot capit ratio object expect continu see correct abl accomplish good amount given market condit still end year zone even kind thing discuss thu far term thing come mix cours year john offic ceo evp cfo inc con call inc
optum remain capit deploy prioriti optum ventur mm
capit led larri renfro
multipl continu expand confid fundament restor
overhang entri reform drug suppli chain ebb
rais pt contempl price-to-earnings ep
speech presid april well beat disclosur
like catalyst
indic strong interest continu build servic busi sa lot platform believ aid significantli perform health system broadli obvious make signific invest care deliveri pretti consist pace respect also invest technolog capit alloc optum ventur see grow number smaller well-suit organ partner realli open sourc innov david scott wichmann ceo director inc con calli think tight interplay consumercentr evolut healthcar system optumcar platform coupl comment know posit lead high-valu medic group ambulatori care organ countri ambit serv market enabl transit value-ori consumer-centr care model improv qualiti experi total cost healthcar andrew hayek ceo optumhealth inc inc con call inc
rais pt
incom servic oper costsmed product oper incom incom earn growth net share dilut earn per ep ep chang growth sg ratio oper sg exclud includ invest incom unitedhealth group inc
care risk-bas risk-bas advantag medicar public servic medic part prescript drug forecast use group individu memberhsip togeth inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings averag ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
